CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer [Phase 2]
Summary
Phase 2 clinical study evaluating pyrotinib in patients with HER2-positive advanced colorectal cancer; status not specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN